Background The optimum timing of sentinel-lymph-node biopsy for breast cancer patients
treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) …

Purpose To determine the detection rate, the false-negative rate, and the accuracy of
sentinel lymph node (SLN) detection after neoadjuvant chemotherapy (NAC) for advanced …

BACKGROUND: As neoadjuvant chemotherapy (NAC) is increasingly used to downstage
patients with breast cancer, the timing of the sentinel node (SN) biopsy has become an …

Background Neoadjuvant chemotherapy for breast cancer has the potential to achieve a
pathological complete response in up to 40 per cent of patients, converting disease that was …

Purpose It is controversial whether sentinel node biopsy (SNB) without axillary dissection
(AD) should be performed in cN1/2 breast cancer patients who become cN0 after …

Background Women with breast cancer are more frequently being treated with preoperative
neoadjuvant chemotherapy. The reliability of sentinel lymph node biopsy (SLNB) following …

Background: Neoadjuvant chemotherapy (NAC) is increasingly used to treat patients with
breast cancer, but the reliability of sentinel lymph node biopsy (SLNB) following …

Introduction In patients with positive lymph nodes (cN+) prior to neoadjuvant treatment
(NAT), which convert to a clinically negative axilla (cN0) after treatment, the use of sentinel …

PURPOSE: Sentinel lymph node (SLN) biopsy has proved to be an accurate method for
detecting nodal micrometastases in previously untreated patients with early-stage breast …

Purpose To provide a systematic review and meta-analysis of studies investigating sentinel
lymph node biopsy after neoadjuvant systemic therapy in pathologically confirmed node …